Assessing the adoption of lopinavir/ritonavir oral pellets for HIV‐positive children in Zimbabwe

INTRODUCTION: Heat‐stable lopinavir/ritonavir (LPV/r) oral pellets were developed to overcome challenges with administration and storage experienced with previously available tablet and syrup forms of LPV/r prescribed to paediatric HIV patients. We report on the adoption of LPV/r pellets for infants...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasipanodya, Briony, Kuwengwa, Rudo, Prust, Margaret L, Stewart, Bethany, Chakanyuka, Christine, Murimwa, Tonderayi, Brophy, Jason, Salami, Olawale, Mushavi, Angela, Apollo, Tsitsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293134/
https://www.ncbi.nlm.nih.gov/pubmed/30549217
http://dx.doi.org/10.1002/jia2.25214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293134/
https://www.ncbi.nlm.nih.gov/pubmed/30549217
http://dx.doi.org/10.1002/jia2.25214

Ejemplares similares